Patent 7537885 was granted and assigned to Lifeblood Medical, Inc. on May, 2009 by the United States Patent and Trademark Office.
The present invention is directed to methods of preserving mammalian heart, ex vivo. Nanoparticle compositions for carrying out the invention are also disclosed.